Hemostasis
3
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
TevaIsrael - Petach Tikva
2 programs2
91-day Levonorgestrel Oral ContraceptivePhase 22 trials
desogestrel/ethinyl estradiol and ethinyl estradiolPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GrifolsHuman thrombin
Tevadesogestrel/ethinyl estradiol and ethinyl estradiol
Teva91-day Levonorgestrel Oral Contraceptive
Teva91-day Levonorgestrel Oral Contraceptive
Medcurahm-P bandage
Clinical Trials (5)
Total enrollment: 1,979 patients across 5 trials
Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery
Start: Dec 2013Est. completion: Nov 2015
Phase 2Completed
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
Start: Oct 2011Est. completion: Sep 2012293 patients
Phase 2Completed
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Start: Nov 2010Est. completion: Dec 2011265 patients
Phase 2Completed
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
Start: Jun 2009Est. completion: Aug 20121,361 patients
Phase 2Completed
Randomized Study of Accelerated Radial Arterial Hemostasis
Start: Nov 2020Est. completion: Jul 202160 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space